First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
While we can’t predict the future, we can help shape it! At Enlyte, our team of experts are continually monitoring emerging trends
Are internet-connected medical devices a cybersecurity risk? The advent of the
Beyond convenience, are there advantages in the use of fixed-dose combination drug products? Fixed-dose combination drug products (FDCDPs
Industry leaders offer unique data and strategies to address trending issues including generative AI, provider shortages, drug costs and regula
At The Forum, the IAIABC's committees and councils discuss policy and administrative issues in workers' compensation, and attendees may also take p
RIMS 2024 Annual Conference & Exhibition is the premier event for the risk management community. RIMS features not only the largest exhibi